SCHEMBL432548

SCHEMBL432548

CCn1/c(=N\N=c2\sc3cc(S(=O)(=O)O)ccc3n2CC)sc2cc(S(=O)(=O)O)ccc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.48
NPSR1 Q6W5P4 8/20 0.43
ALDH1A1 P00352 7/20 0.43
TSHR P16473 3/20 0.43
PKM P14618 2/20 0.43
SMN1; SMN2 Q16637 3/20 0.41
KDM4E B2RXH2 6/20 0.39
NPC1 O15118 1/20 0.39
RECQL P46063 1/20 0.39
RAB9A P51151 1/20 0.39
PPARG P37231 1/20 0.39
NCOA2 Q15596 1/20 0.39
NCOA1 Q15788 1/20 0.39
NCOA3 Q9Y6Q9 1/20 0.39
MAPK1 P28482 1/20 0.38
HPGD P15428 4/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
GAA P10253 2/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7915441 1.00 MAPT (0.48) MAPTNPSR1ALDH1A1TSHRPKM
SCHEMBL30132089 1.00 MAPT (0.48) MAPTNPSR1ALDH1A1TSHRPKM
SCHEMBL14599149 1.00 MAPT (0.48) MAPTNPSR1ALDH1A1TSHRPKM
SCHEMBL63297 1.00 MAPT (0.48) MAPTNPSR1ALDH1A1TSHRPKM
SCHEMBL13458992 1.00 MAPT (0.48) MAPTNPSR1ALDH1A1TSHRPKM
Ammonia Solution, Strong SCHEMBL2319900 0.99 MAPT (0.47) MAPTNPSR1ALDH1A1TSHRPKM
Ammonia Solution, Strong SCHEMBL306103 0.99 MAPT (0.47) MAPTNPSR1ALDH1A1TSHRPKM
Ammonia Solution, Strong SCHEMBL21840 0.99 MAPT (0.47) MAPTNPSR1ALDH1A1TSHRPKM
Ammonia Solution, Strong SCHEMBL21839 0.99 MAPT (0.47) MAPTNPSR1ALDH1A1TSHRPKM
Hydrogen Peroxide SCHEMBL5566292 0.99 MAPT (0.47) MAPTNPSR1ALDH1A1TSHRPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 858 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250195432-A1 METHODS FOR PREPARING AND CHARACTERIZING ZEIN-FUCOIDAN CONJUGATED NANO-LIPOSOME FOR PHYTOL ENCAPSULATION ZHEJIANG ACADEMY OF FORESTRY (CN) 2025-06-19 US claimed
US-20250177284-A1 COSMETIC COMPOSITION FOR IMPROVING SKIN CONTAINING EXTRACTS OF POLYGALA TENUIFOLIA, ANGELICA DAHURICA AND ELSHOLTZIA SPLENDENS SOOY-K CO., LTD. (KR) 2025-06-05 US claimed
WO-2025105566-A1 SKIN IMPROVEMENT COSMETIC COMPOSITION COMPRISING EXTRACTS OF POLYGALA TENUIFOLIA, ANGELICA DAHURICA AND ELSHOLTZIA SPLENDENS (주) 수이케이 2025-05-22 WO claimed
US-20250034621-A1 LOCKED APTAMER HAIRPIN INTEGRATED HYBRIDIZATION CHAIN REACTION FOR RAPID, INSTRUMENT-FREE BIOMARKER DETECTION THE TEXAS A&M UNIVERSITY SYSTEM 2025-01-30 US claimed
WO-2024151479-A1 CONTAINERS AND METHODS FOR NITRIC OXIDE STERILIZATION STERILE STATE, LLC (US) 2024-07-18 WO claimed
US-20240082445-A1 Devices and Methods for Detecting the Presence of Nitric Oxide STERILE STATE LLC (US) 2024-03-14 US claimed
EP-4285117-A1 DEVICES AND METHODS FOR DETECTING THE PRESENCE OF NITRIC OXIDE Sterile State LLC (US) 2023-12-06 EP claimed
EP-3488045-B1 METHOD FOR LIGNIN DEPOLYMERISATION METGEN OY (FI) 2023-08-30 EP claimed
WO-2022164905-A1 DEVICES AND METHODS FOR DETECTING THE PRESENCE OF NITRIC OXIDE STERILE STATE LLC (US) 2022-08-04 WO claimed
WO-2022092461-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OBESITY OR DIABETES, AND PREPARATION METHOD THEREFOR 원광대학교산학협력단 2022-05-05 WO claimed
US-20040219620-A1 Chromogenic substrate with a pH indicator dye NEOGEN CORPORATION 2004-11-04 US claimed
US-20040040098-A1 Compositions for the oxidation dyeing of keratin fibers and dyeing processes using these compositions L'OREAL 2004-03-04 US claimed
EP-1153166-A2 ENZYMATIC METHODS FOR DYEING WITH REDUCED VAT AND SULFUR DYES Novozymes Biotech, Inc. (US) 2001-11-14 EP claimed
WO-2000031333-A2 ENZYMATIC METHODS FOR DYEING WITH REDUCED VAT AND SULFUR DYES NOVOZYMES BIOTECH, INC. (US) 2000-06-02 WO claimed
US-5702955-A Ascorbate resistant detection of hydrogen peroxide BAYER CORPORATION (US) 1997-12-30 US claimed
EP-0744619-A1 Ascorbate resistant detection of hydrogen peroxide Bayer Corporation (US) 1996-11-27 EP claimed
EP-0261591-B1 METHOD FOR ASSAYING 1,5-ANHYDROGLUCITOL AND KIT THEREFOR NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1993-03-10 EP claimed
EP-0148275-B1 PROCESS FOR DECOMPOSING ASCORBIC ACID WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 1992-09-02 EP claimed
US-4546076-A PRODUCTION OF D-ALANINE AND QUANITATIVE ANALYSIS THEREOF U C B SOCIETE ANONYME (BE) 1985-10-08 US claimed
EP-0148275-A1 PROCESS FOR DECOMPOSING ASCORBIC ACID WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 1985-07-17 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040040098-A1 Compositions for the oxidation dyeing of keratin fibers and dyeing processes using these compositions KRT18, PPOX, POR MAPT 2195/4885NPSR1 4086/4885ALDH1A1 164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.